Mo Daf (@MoDafaalla) header
Mo Daf (@MoDafaalla) profile picture

Keele Uni Phd fellow/Cardiology registrar NHS ENGLAND تجري الرياح كما تجري سفينتنا......فنحن الرياح، ونحن البحر والسفن

Stoke-on-Trent, England
Joined May 2016
The PRECISE-DAPT Cancer score... Our article published in the EHJ (IF 39) is now available.......
1. Bleeding risk prediction after acute myocardial infarction-integrating cancer data: the updated PRECISE-DAPT cancer score academic.oup.com/eurheartj/a… our work led by @MoDafaalla
2
1,582
Please don't mislead your readers. I'm at the airport and there is no smoke, no fire and nothing much else for that matter- apart from lots of nice shops and travellers. The most dangerous situation I faced in Riyadh over the last couple of days was being overfed by my Saudi friends at our cardiology congress @TCT_ME_
6
43
154
18,386
الناس القاعدة او عندها تواصل مباشر بالسودان... ممكن تدونا لمحة عن تكاليف المعيشة الشهرية لأسرة بطفل (من غير ايجار)...بعد نزول العملة...
85
I successfully defended my PhD Thesis at Keele university. It was a long journey full of great achievements...started as ACF and continued as a PhD fellow A huge thank you to my supervisors @mmamas1973 and @drrashid05 who guided me along the way
7
2
1
21
5,386
I am delighted to share with you that I passed the BCIS ICI accreditation exam today...
1
8
278
At the conclusion of 2025 the @SaudiMedJ has undergone an overhaul A task force met with national & international experts, trialists, university leaders, editors & society presidents to standardize & improve the editorial process We have enlisted the contributions of guest editors who have served as PIs of landmark trials & society leaders to review consensus documents which will be published in 2026 It’s an opportunity to thank all contributors to the journal & hoping 2026 will register high quality science through the journal
5
39
2,261
SELUTION DeNovo - non inferiority for TVF at 1 yr demonstrated. Randomisation before lesion prep ➡️ 20% DES use in DEB arm ➡️ 50% non inferiority margin of overall tvf in both arms !!!!! ➡️ TVF 4.4 vs 5.3% in des and deb arms This is a landmark moment- analogous to introduction of DES (even with generous non inferiority margin) #TCT2025 @crfheart Wild clapping in audience @Hragy @jgranadacrf @mirvatalasnag @drptca @SrihariNaiduMD @realarainmd @DrAsifQasim @DavidWienerMD @sbrugaletta @alaide_chief
7
46
2
169
26,607
My talk about management of AMI in cancer patients- highlighting use of precise-Dapt cancer score to guide your DAPT strategy #ESCCongress @JGrapsa @sbrugaletta @mirvatalasnag @purviparwani @ProfDConnelly @AnastasiaSMihai @iamritu @Hragy @hvanspall @BartoszHudzik @DrMarthaGulati @Marta33717088 @vass_vassiliou
5
34
4
121
10,411
Join us in Riyadh and learn and share with us #InnovateDontReplicate @mirvatalasnag @AlkashkariWail @drptca @kfaraidy
Replying to @crfheart
@crfheart @TCTConference @TCTMD ░ Innovate..Educate ░ Join us April 9-11, 2026 in Riyadh >>..•.¸¸•`¯´•.¸¸>> “The intersection of innovators, investigators & investors” 🔗 tctmiddleeast2025.crfconfere…
5
21
3,321
The first edition was extremely successful and inspiring. This upcoming edition #TCTMiddleEast2026 will be truly something exceptional and different. We are expecting ~5000 attendees. #InnovateDontReplicate. #TCTMiddleEast2026 bridging the world four directions together.
Replying to @crfheart
@crfheart @TCTConference @TCTMD ░ Innovate..Educate ░ Join us April 9-11, 2026 in Riyadh >>..•.¸¸•`¯´•.¸¸>> “The intersection of innovators, investigators & investors” 🔗 tctmiddleeast2025.crfconfere…
2
7
19
3,791
Our editorial in @CJCJournals led by @NachoLarrubia @mavigaru902 and myself on the debated topic of potent P2Y12i in cancer pts: food4thoughts, no RCT available & no risk prediction tools validated for decision making. @mmamas1973 @MoDafaalla @ovidiodefilippo @Fabri84Dascenzo
✍️ This new #editorial discusses a study that supports the concept that patients in remission who do not meet strict HBR criteria might safely derive ischemic benefit from potent antiplatelet strategies, mirroring what is routinely done in the general population - thus avoiding undertreatment attributable to the “cancer label.” ⬇️ onlinecjc.ca/article/S0828-2… @NachoLarrubia #CJC
2
2
9
821
Successfully passed the European Exam in Core Cardiology. An important milestone in my journeyas a cardiology trainee. A owe my successfully to all my mentors along the way especially @mmamas1973 and @drrashid05
3
117
✅ولله الحمد نشر فريقنا البحثي اكبر قاعدة بيانات عن امراض القلب،العيوب الخلقية وانحراف القلب في المملكه العربية السعودية والشرق الاوسط. ✅هذا العمل يمثل خطوه مهمه نحو فهم أفضل لطبيعة الامراض وطرق العلاج. j-saudi-heart.com/jsha/vol37… #Dextrocardia #structural_disease
6
19
3,757
احمد الله واشكره بأن سخرني اليوم لعمل قسطره قلبيه معقده لحاج وفتح الشريان الرئيسي للقلب (نسبة الوفاه بدون تدخل 90-100%) بمشعر عرفات في معمل القسطرة المتنقلة(يستخدم لاول مره على مستوى العالم في الحشود الضخمه في الحالات الطارئه) ومن ثم وضع جهاز الايكمو (ايضا لاول مره في تاريخ المشاعر المقدسه ) مما أدى إلى استقرار حالة الحاج وإدخال البهجه لاسرته.. إن هذه الامكانيات التي وفرتها حكومة مولاي خادم الحرمين الشريفين وولي عهده الأمين تؤكد بأنه الحج والحجيج في أفضل وأطهر الأيادي. وإني اسأل الله بهذا العمل ان يديم الامن والامان والرخاء لبلدي العظيم 🇸🇦🇸🇦🇸🇦🇸🇦
إنقاذ حاج باكستاني من حالة وفاة محتمة.. رئيس الجمعية السعودية لقسطرة القلب د. وائل القشقري يطلعنا على تفاصيل الحالة #الحج_عبر_الإخبارية
44
103
7
428
125,246
Excited to continue this journey of innovation, education and late breaking science across the whole of the Middle East Join us on our journey and partner with us #InnovateDontReplicate
Mark Your Calendars: TCT Plus Middle East Returns! Get ready to join us next year as we continue advancing innovation, education, and clinical excellence across the region. #TCTMiddleEast2026 📍 Riyadh, Saudi Arabia 📅 April 9–11, 2026 🔗 More info coming soon! tctmiddleeast2025.crfconfere… #CardioX #CardioTwitter #CardioEd #CardioResearch @jgranadacrf @triciarawh @TCTConference @mirvatalasnag @kfaraidy @drptca @mmamas1973 @AlkashkariWail @TCT_ME_ @TCTMD
7
1
27
6,404
I presented our NAGOMI complex PCI trial data at EuroPCR ➡️ 3000 patients from 13 countries across 52 sites. ➡️ 44% of complex PCI patients were HBR ➡️ TLF rates at 30 days 1.4% @terumoisuk @Hragy @KardiologieHH @sbrugaletta @alaide_chief @mirvatalasnag @aayshacader @DrPeterOKane @NickCurzen
4
26
1
80
8,014
#TCTMiddleEast Selfie with Dr. Mirvat Alasnag. Thank you for having me. Very much appreciated. @AlkashkariWail @mmamas1973 @mirvatalasnag @drptca
1
3
9
1,311
#TCTMiddleEast Selfie with Dr. Khaled Alshaib Thank you for having me. Very much appreciated. @AlkashkariWail @mmamas1973 @mirvatalasnag @drptca
1
2
1
7
904